Abstract
Bronchopulmonary Dysplasia (BPD) continues to be a major problem despite advances in the management of the sick preterm. Current evidence supports a multifactorial etiology to this disease. Prematurity is the cardinal factor; others include pulmonary baro/volu trauma, hyperoxia, and inflammation. A clearer understanding of genetic susceptibility for BPD has recently emerged. Twin studies have shown that 53% of the variance for BPD is genetic. This article will attempt to review the published literature appraising the relationship between single nucleotide polymorphisms of putative causal genes and susceptibility to BPD. These studies, though small in size, spark interest in further genetic association studies to identify candidate genes that contribute to the diverse pathophysiology of BPD.
Keywords: Lung, single nucleotide polymorphisms, cytokines, preterm newborn
Current Respiratory Medicine Reviews
Title: Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Volume: 2 Issue: 3
Author(s): Anupama Shetty, Jeffrey R. Gruen and Vineet Bhandari
Affiliation:
Keywords: Lung, single nucleotide polymorphisms, cytokines, preterm newborn
Abstract: Bronchopulmonary Dysplasia (BPD) continues to be a major problem despite advances in the management of the sick preterm. Current evidence supports a multifactorial etiology to this disease. Prematurity is the cardinal factor; others include pulmonary baro/volu trauma, hyperoxia, and inflammation. A clearer understanding of genetic susceptibility for BPD has recently emerged. Twin studies have shown that 53% of the variance for BPD is genetic. This article will attempt to review the published literature appraising the relationship between single nucleotide polymorphisms of putative causal genes and susceptibility to BPD. These studies, though small in size, spark interest in further genetic association studies to identify candidate genes that contribute to the diverse pathophysiology of BPD.
Export Options
About this article
Cite this article as:
Shetty Anupama, Gruen R. Jeffrey and Bhandari Vineet, Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778018935
DOI https://dx.doi.org/10.2174/157339806778018935 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetic Retinopathy, Superoxide Damage and Antioxidants
Current Pharmaceutical Biotechnology Phytosterols in Physiological Concentrations Target Multidrug Resistant Cancer Cells
Medicinal Chemistry Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Formulated Squalene for Food Related Applications
Recent Patents on Food, Nutrition & Agriculture Risk Factors and Potential Preventive Measures for Vascular Disease Progression in Hemodialysis Patients
Vascular Disease Prevention (Discontinued) Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued) Evaluation of Left Ventricular Volumes and Ejection Fraction from Gated Myocardial Perfusion SPECT Processed with “Myovation Evolution”: Comparison of Three Automated Software Packages using Cardiac Magnetic Resonance as Reference
Current Radiopharmaceuticals Adenosine A<sub>3</sub> Receptor: A promising therapeutic target in cardiovascular disease
Current Cardiology Reviews Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging Rhinovirus-Associated Wheeze During Infancy and Asthma Development
Current Respiratory Medicine Reviews Serum Uric Acid and Risk of Coronary Heart Disease
Current Pharmaceutical Design Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes
Current Diabetes Reviews Oxidative Stress-Induced Ischemic Heart Disease: Protection by Antioxidants
Current Medicinal Chemistry Efficacy and Cardiovascular Safety of Alpha Glucosidase Inhibitors
Current Drug Safety Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Associations of Body Mass Index and Obesity-Related Genetic Variants with Serum Metabolites
Current Metabolomics Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Atheroprotective Effects of HDL: Beyond Reverse Cholesterol Transport
Current Drug Targets